Home › Ulcerative Colitis › South Carolina
Ulcerative Colitis clinical trials in South Carolina
14 studies for Ulcerative Colitis are looking for participants at sites in South Carolina.
Cities in South Carolina
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Medical University of South Carolina, Charleston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Associates - Patewood, Greenville
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Associates, P.A. of Greenville, Greenville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07186101A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07577856A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07697456A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Patewood Medical Campus /ID# 272477, Greenville
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Oct 27, 2026 · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Medical University of South Carolina (MUSC), Charleston
RecruitingObservational study
Ages 18 to 64 · All sexes · Updated Oct 26, 2026 · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Biocentric Health Research Partner, West Columbia
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 23, 2026 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0099, Charleston
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Oct 20, 2026 · NCT05076175A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Oct 9, 2026 · NCT06405087BOOM-IBD2 Pivotal Clinical Trial
- Columbia Digestive Health Research (Objective Health), Columbia
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 3, 2026 · NCT06100289A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.